Gemcitabine/Oxaliplatin (GEMOX) With or Without Erlotinib (Tarceva) in Advanced Biliary Tract Carcinoma

NCT01149122 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

266

Enrollment

OTHER

Sponsor class

Conditions

Unresectable, Metastatic Biliary Tract Carcinoma

Interventions

DRUG: Gemcitabine/Oxaliplatin
DRUG: Gemcitabine/Oxaliplatin with Erlotinib (Tarceva)

Sponsor

Samsung Medical Center